About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- First confirm source: haemoptysis is lower respiratory bleeding; epistaxis/oropharyngeal bleeding and haematemesis can mimic it
- Massive haemoptysis is an airway emergency — death is usually from asphyxiation, not exsanguination
- Must-not-miss causes: lung cancer, TB, PE, bronchiectasis with major bleed, diffuse alveolar haemorrhage/vasculitis, and anticoagulation-related bleeding
- Initial tests: vitals, airway assessment, CBC, coagulation profile, renal function, type and screen if significant, CXR; CT chest/CT angiography is usually the key next test when stable
- Suspected TB requires airborne precautions, sputum AFB/NAAT/culture, and public health notification in Canada
Approach to the Presentation
The MCC objective for blood in sputum emphasises stability, risk factors, and exclusion of alternative bleeding sources. Begin with ABCs: active large-volume bleeding, hypoxia, respiratory distress, or haemodynamic instability demands emergency airway planning and specialist involvement. Clarify volume, frequency, clots, sputum colour, fever, chronic cough, weight loss, TB exposure, smoking/asbestos, anticoagulants, VTE risk, renal symptoms, and epistaxis/GI symptoms. For small-volume haemoptysis in a stable patient, CXR followed by CT chest when risk factors or abnormal imaging are present is a common pathway; for massive haemoptysis, airway control and localisation of bleeding take priority.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Lung Cancer | must-not-miss | Older age, smoking, asbestos/radon exposure, weight loss, anorexia, hoarseness, recurrent pneumonia, clubbing, persistent or recurrent haemoptysis | CXR then CT chest with contrast; tissue diagnosis by bronchoscopy or CT-guided biopsy |
| Tuberculosis | must-not-miss | Cough >2-3 weeks, fever, night sweats, weight loss, haemoptysis, TB contact, high-incidence country exposure, shelter/incarceration, immunocompromise | CXR + sputum AFB smear/culture and NAAT; public health notification |
| Pulmonary Embolism / Pulmonary Infarction | must-not-miss | Pleuritic chest pain, acute dyspnoea, tachycardia, syncope, risk factors for VTE; haemoptysis usually small volume | Clinical probability pathway + D-dimer or CTPA |
| Diffuse Alveolar Haemorrhage / Vasculitis | must-not-miss | Haemoptysis with dyspnoea, anaemia, diffuse infiltrates, renal involvement (haematuria/proteinuria), purpura, sinus symptoms. Causes: ANCA vasculitis, anti-GBM, SLE | CT chest, falling haemoglobin, urinalysis, creatinine, ANCA, anti-GBM, bronchoscopy with BAL |
| Bronchiectasis | common | Chronic productive cough, recurrent infections, large sputum volumes, coarse crackles, history of severe childhood infections, CF, immunodeficiency, or post-TB disease | HRCT showing bronchial dilation; sputum culture |
| Pneumonia / Necrotising Infection | common | Fever, purulent sputum, pleuritic pain, focal crackles, consolidation. Haemoptysis may occur with severe inflammation or necrosis | CXR infiltrate; CBC and cultures if severe/admitted |
| Acute Bronchitis | common | Small streaks of blood after forceful coughing with viral URI symptoms; normal vitals and CXR; no systemic red flags | Clinical diagnosis after excluding red flags; CXR if persistent or risk factors |
| Anticoagulation / Coagulopathy | common | Warfarin, DOACs, antiplatelets, thrombocytopenia, liver disease, supratherapeutic INR; bleeding may unmask underlying lesion | CBC, INR/PTT, renal/liver function; still evaluate for pulmonary source if haemoptysis is real |
| Pseudohaemoptysis / Haematemesis | common | Blood from nose/oropharynx, gingival bleeding, or vomiting blood. Haematemesis often dark/coffee-ground, nausea, melena; haemoptysis usually frothy and mixed with sputum | Focused ENT/oral exam; GI assessment if haematemesis suspected |
| Mitral Stenosis / Pulmonary Venous Hypertension | less common | Dyspnoea, orthopnoea, AF, opening snap/diastolic murmur, pulmonary oedema; historically associated with rheumatic disease | Echocardiography |
Red Flags & Key History
Symptoms
Large-volume bleeding, clots, recurrent bleeding, dyspnoea, or inability to clear airway
Weight loss, night sweats, fever, TB exposure, or immunocompromise
Smoking history, asbestos exposure, age >40, hoarseness, recurrent pneumonia
Pleuritic chest pain, syncope, tachycardia, VTE risk factors
Haematuria, renal dysfunction, purpura, sinus disease — pulmonary-renal syndrome
Recent forceful coughing with scant blood-streaking and viral symptoms
Signs
Respiratory distress, hypoxia, altered mental status — airway at risk
Unilateral crackles/wheeze may localise bleeding side
Fever, focal consolidation, or sepsis signs
Clubbing or lymphadenopathy — malignancy, bronchiectasis, chronic suppurative disease
Petechiae, bruising, mucosal bleeding — coagulopathy or thrombocytopenia
Approach to Investigation
First-line
CXRInitial imaging for most stable patients. May show mass, cavitation, pneumonia, TB changes, alveolar infiltrates, effusion. Normal CXR does not exclude cancer or bronchiectasis
CBC + coagulation profileHaemoglobin trend, platelets, INR/PTT. Add type and screen/crossmatch if significant or ongoing bleeding
Renal function + urinalysisCreatinine for CT contrast and anticoagulant dosing; haematuria/proteinuria suggests pulmonary-renal syndrome
Medication reviewWarfarin, DOACs, antiplatelets, NSAIDs, thrombolytics. Check timing and renal function for DOAC effect
Second-line
CT chest with contrast / CT angiographyPreferred next test in many stable patients with risk factors, abnormal CXR, recurrent haemoptysis, or moderate-large volume bleeding; helps localise bleeding and identify cancer, bronchiectasis, PE, vascular lesions
Sputum microbiologySputum culture if infection suspected. AFB smear/culture and NAAT if TB is possible; use airborne precautions while evaluating infectious TB
Autoimmune testingANCA, anti-GBM, ANA/complements if diffuse alveolar haemorrhage, renal involvement, purpura, or systemic symptoms
Specialist
BronchoscopyFor airway control/localisation in massive haemoptysis, suspected endobronchial lesion, persistent unexplained haemoptysis, or need for sampling
Bronchial artery embolisationKey therapy for ongoing or recurrent significant haemoptysis when bronchial arterial source is identified
Thoracic surgery / interventional respirologyIf malignancy, refractory bleeding, localised surgically resectable disease, or airway intervention is required
Management Principles
MCC Blood in Sputum Objective + Canadian Tuberculosis Standards + CAEP emergency stabilisation principles1
Massive or unstable haemoptysis
- Call anaesthesia/ICU/respirology/thoracic surgery/interventional radiology early
- Position bleeding side down if known to protect the non-bleeding lung
- High-flow oxygen, suction, large-bore IV access, crossmatch blood, reverse coagulopathy where appropriate
- Secure airway with large-bore endotracheal tube if needed; consider selective mainstem intubation or bronchial blocker by expert operators
- Localise and control bleeding: bronchoscopy and/or CT angiography followed by bronchial artery embolisation when appropriate
2
Stable small-volume haemoptysis
- Confirm true haemoptysis and assess risk factors
- CXR and basic labs; CT chest if abnormal CXR, recurrent bleeding, cancer/TB risk, age/smoking risk, or unexplained presentation
- Treat cause: antibiotics for pneumonia, asthma/COPD management if bronchitis/exacerbation, adjust/reverse anticoagulation if clinically necessary
3
Suspected TB or transmissible infection
- Airborne precautions and mask the patient
- Collect sputum for AFB smear/culture and NAAT according to local/public health process
- Notify public health; treatment is multidrug and coordinated with TB specialists/public health in Canada
Complications & Pitfalls
- Underestimating airway risk: Massive haemoptysis kills by airway flooding/asphyxia; haemodynamic stability can be misleading.
- Failure to isolate TB: Chronic cough with haemoptysis and systemic symptoms should trigger airborne precautions and public health notification.
- Normal CXR false reassurance: Lung cancer, bronchiectasis, PE, and early TB can be missed on plain film.
- Stopping at anticoagulation: Anticoagulants can worsen bleeding but may reveal cancer, infection, or bronchiectasis — evaluate the underlying source.
- Misidentifying haematemesis: Ask about nausea, melena, epistaxis, and inspect the mouth/nose before committing to a pulmonary pathway.
MCCQE1 Exam Tips
- 1The first step in large-volume haemoptysis is airway protection, not CT
- 2Bleeding side down is a classic next-best-step manoeuvre to protect the good lung
- 3Haemoptysis + chronic cough + night sweats/weight loss = TB workup and airborne precautions
- 4Haemoptysis + smoking + weight loss/hoarseness = lung cancer until proven otherwise
- 5Haemoptysis + renal impairment/haematuria = pulmonary-renal syndrome; think ANCA vasculitis or anti-GBM disease
- 6CT chest is often more informative than bronchoscopy in stable haemoptysis, but bronchoscopy is critical for airway control and endobronchial lesions
- 7CanMEDS professional/health advocate: suspected TB has public health duties, not just individual patient care
practicetest your knowledge on haemoptysisApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — respiratory and beyond.
open q-bank